Vor Biopharma Closes Over $203.4 Million Initial Public Offering of Shares of Common Stock Trading on the NASDAQ Global Market
CFGI’s Capital Markets team assisted Vor Biopharma (NASDAQ: VOR) with their initial public offering.
Ortho Clinical Diagnostics Holdings PLC Closes $1.49 Billion Initial Public Offering of Ordinary Shares Trading on the NASDAQ Global Select Market
CFGI’s Capital Markets team assisted Ortho Clinical Diagnostics Holdings PLC (NASDAQ: OCDX) with their initial public offering.
Clene Nanomedicine Inc. Closes Business Combination with SPAC Tottenham Acquisition I Limited
CFGI’s Capital Markets team assisted Clene Nanomedicine (“Clene”) (NYSE: CLNN) with its SPAC merger with Tottenham Acquisition I Limited (“Tottenham”).
indie Semiconductor and Thunder Bridge Acquisition II, Ltd. Close Business Combination
CFGI’s Capital Markets team assisted indie Semiconductor (“indie”) (NYSE: INDI) with its SPAC merger with Thunder Bridge Acquisition II.
Capital Markets Advisory: 2020 Year in Review
Despite the impact of the pandemic, 2020 was a record year for the U.
SPAC Mergers Are a Popular (and Accelerated)
Way to Go Public
SPACs became ever more popular through 2020 and 2021, with SPAC IPOs raising more than $245 billion over the past two years.